Eli Lilly (LLY)

AI-powered earnings call analysis for Eli Lilly. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.

10 episodes 5 languages

Next Episode

Eli Lilly earnings call scheduled for Aug 5, 2026 (before market open)

New episode expected Aug 6, 2026

Latest Episode

Q1 2026 Earnings

7:28 • 4/30/2026

Eli Lilly (LLY) - Q1 2026

0:00

7:28

Speed:

Q1 2026 Earnings

9:32 • 2026/4/30

Eli Lilly (LLY) - Q1 2026

0:00

9:32

Speed:

Q1 2026 Earnings

11:32 • 30/04/2026

Eli Lilly (LLY) - Q1 2026

0:00

11:32

Speed:

Q1 2026 Earnings

10:59 • 30/4/2026

Eli Lilly (LLY) - Q1 2026

0:00

10:59

Speed:

Q1 2026 Earnings

9:03 • 30.4.2026

Eli Lilly (LLY) - Q1 2026

0:00

9:03

Speed:

All Episodes

EN - English (2) CN - 中文 (2) FR - Français (2) ES - Español (2) DE - Deutsch (2)

Q1 2026 Earnings

7:28

Eli Lilly delivered 56% revenue growth in Q1 2026 driven by Mounjaro and Zepbound momentum, launched Koundeo for obesity with encouraging early uptake, and announced five positive Phase III trials plus four strategic acquisitions to expand its immunology, oncology, and neuroscience portfolios.